J. Biochem, 1990, Vol. 107, No. 5 787-793
© 1990 Japanese Biochemical Society
research-article |
Biochemical and Immunological Studies on Two Distinct Ganglioside-Hydrolyzing Sialidases from the Particulate Fraction of Rat Brain1
*Biochemistry Laboratory, Research Institute for Tuberculosis and Cancer, Tohoku University Aoba-ku, Sendari, Miyagi 980
**Department of Biochemistry, Tokyo Medical and Dental University Bunkyo-ku, Tokyo 113
To whom correspondence should be addressed.
Ganglioside-hydrolyzing sialidases activity was solubilized from rat brain particulate fraction by using Triton X-100 plus sodium deoxycholate. When chromatographed on AH-Sepharose 4B, the solubilized activity was resolved into two peaks, which were designatede sialidases I and II in order of elution. The two sialidases were purified by using sequential chromatographies on OctyI-Sepharose CL-4B, PhenyI-Sepharose CL-4B, and Sephadex G200. Sialidase II was purified further by Mono Q-FPLC. Overall purification was 450- and 2, 150-fold, for sialidases I and II, respectively. Purified sialidases I and II were maximally active at near pH 5.0 and exhibited Mi = 70, 000 by gel filtration. Sialidase I hydrolyzed gangliosides but scarcely other substrates including 4-methylumbelliferyI-NeuAc (4MU-NeuAc). Sialidase II hydrolyzed oligosaccharides, glycoproteins, and 4MU-NeuAc although gangliosides appeared to be preferential substrates. Sialidase II cleaved GM2 much faster than sialidase I. An antibody raised in rabbits against sialidase I reacted with only sialidase I and an antibody against sialidase II reacted with only sialidase II. A subcellular distribution study suggested sialidase I in the synaptosomal membrane and sialidase II in the synaptosomal and lysosomal membranes, and this was verified by using the above antibodies.
1 This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Valaperta, V. Chigorno, L. Basso, A. Prinetti, R. Bresciani, A. Preti, T. Miyagi, and S. Sonnino Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts FASEB J, June 1, 2006; 20(8): 1227 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Papini, L. Anastasia, C. Tringali, G. Croci, R. Bresciani, K. Yamaguchi, T. Miyagi, A. Preti, A. Prinetti, S. Prioni, et al. The Plasma Membrane-associated Sialidase MmNEU3 Modifies the Ganglioside Pattern of Adjacent Cells Supporting Its Involvement in Cell-to-Cell Interactions J. Biol. Chem., April 23, 2004; 279(17): 16989 - 16995. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sasaki, K. Hata, S. Suzuki, M. Sawada, T. Wada, K. Yamaguchi, M. Obinata, H. Tateno, H. Suzuki, and T. Miyagi Overexpression of Plasma Membrane-associated Sialidase Attenuates Insulin Signaling in Transgenic Mice J. Biol. Chem., July 18, 2003; 278(30): 27896 - 27902. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sasaki, Y. Akimoto, Y. Sato, H. Kawakami, H. Hirano, and T. Endo Distribution of Sialoglycoconjugates in the Rat Cerebellum and Its Change with Aging J. Histochem. Cytochem., September 1, 2002; 50(9): 1179 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kakugawa, T. Wada, K. Yamaguchi, H. Yamanami, K. Ouchi, I. Sato, and T. Miyagi Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression PNAS, August 6, 2002; 99(16): 10718 - 10723. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, Y. Akimoto, H. Kawakami, H. Hirano, and T. Endo Location of Sialoglycoconjugates Containing the Sia{alpha}2-3Gal and Sia{alpha}2-6Gal Groups in the Rat Hippocampus and the Effect of Aging on Their Expression J. Histochem. Cytochem., October 1, 2001; 49(10): 1311 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hasegawa, K. Yamaguchi, T. Wada, A. Takeda, Y. Itoyama, and T. Miyagi Molecular Cloning of Mouse Ganglioside Sialidase and Its Increased Expression in Neuro2a Cell Differentiation J. Biol. Chem., March 10, 2000; 275(11): 8007 - 8015. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Katoh, T. Miyagi, H. Taniguchi, Y.-i. Matsubara, J.-i. Kadota, A. Tominaga, P. W. Kincade, S. Matsukura, and S. Kohno Cutting Edge: An Inducible Sialidase Regulates the Hyaluronic Acid Binding Ability of CD44-Bearing Human Monocytes J. Immunol., May 1, 1999; 162(9): 5058 - 5061. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyagi, T. Wada, A. Iwamatsu, K. Hata, Y. Yoshikawa, S. Tokuyama, and M. Sawada Molecular Cloning and Characterization of a Plasma Membrane-associated Sialidase Specific for Gangliosides J. Biol. Chem., February 19, 1999; 274(8): 5004 - 5011. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Milner, S. V. Smith, M. B. Carrillo, G. L. Taylor, M. Hollinshead, and R. D. Campbell Identification of a Sialidase Encoded in the Human Major Histocompatibility Complex J. Biol. Chem., February 14, 1997; 272(7): 4549 - 4558. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Bonten, A van der Spoel, M Fornerod, G Grosveld, and A d'Azzo Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes & Dev., December 15, 1996; 10(24): 3156 - 3169. [Abstract] [PDF] |
||||





